← Back to Search

Acid

Vinegar for Metabolic Syndrome

N/A
Waitlist Available
Led By Carol S Johnston, PhD
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at week 4
Awards & highlights

Study Summary

This trial tests if drinking vinegar can help overweight adults improve their metabolic health.

Who is the study for?
This trial is for healthy, overweight adults with a BMI between 25 and 35 who don't smoke or have chronic diseases. Participants must speak English and not be pregnant, lactating, vegetarian, suffer from regular heartburn or GERD, on weight loss diets, using drugs recreationally or drinking alcohol excessively.Check my eligibility
What is being tested?
The study is testing whether consuming vinegar daily can improve metabolic health in overweight individuals. It compares the effects of liquid vinegar to vinegar pills over a period of four weeks.See study design
What are the potential side effects?
Potential side effects may include digestive discomfort such as upset stomach or acid reflux due to the acidity of vinegar. Individuals might also experience changes in appetite or taste aversion.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at week 4
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at week 4 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Depression score
gamma-aminobutyric acid (GABA)
Secondary outcome measures
Inflammation
LPS
metabolic syndrome

Side effects data

From 2012 Phase 2 trial • 56 Patients • NCT00540722
38%
fatigue
7%
vomiting
7%
Rash maculo-papular
7%
peripheral sensory neuropathy
7%
constipation
5%
diarrhea
5%
anorexia
2%
Seizure
2%
lleus
2%
cardiac disorder other
2%
hypophosphatemia
100%
80%
60%
40%
20%
0%
Study treatment Arm
Treatment (R-(-)-Gossypol Acetic Acid)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Liquid vinegarExperimental Treatment1 Intervention
4 tablespoons BID per day (3000 mg acetic acid)
Group II: Vinegar pillPlacebo Group1 Intervention
2 vinegar pills per day (30 mg acetic acid)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Liquid vinegar
2023
N/A
~40

Find a Location

Who is running the clinical trial?

Arizona State UniversityLead Sponsor
283 Previous Clinical Trials
109,478 Total Patients Enrolled
1 Trials studying Metabolic Syndrome
424 Patients Enrolled for Metabolic Syndrome
Carol S Johnston, PhDPrincipal InvestigatorArizona State University

Media Library

Vinegar (Acid) Clinical Trial Eligibility Overview. Trial Name: NCT05698381 — N/A
Metabolic Syndrome Research Study Groups: Liquid vinegar, Vinegar pill
Metabolic Syndrome Clinical Trial 2023: Vinegar Highlights & Side Effects. Trial Name: NCT05698381 — N/A
Vinegar (Acid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05698381 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are octogenarians being included in the pool of potential participants for this medical experiment?

"This investigation is only open to individuals aged between 18 and 40. Conversely, there are 578 clinical trials for minors and 2103 studies dedicated to seniors."

Answered by AI

How many individuals are involved in this experiment?

"Affirmative. Clinicaltrials.gov's records show that, since its initial posting on February 1st 2023, this clinical trial has been searching for 40 participants at one location. The information was last updated on January 16th 2023."

Answered by AI

Is there any vacancy available to join this trial?

"Absolutely. Clinicaltrials.gov's data indicates that the trial, first posted on February 1st 2023, is still actively searching for 40 patients from one location. The listing was most recently updated on January 16th 2023."

Answered by AI

Who is eligible to participate in this experiment?

"Forty participants, aged between 18 and 40 years old with inflammation, who are healthy non-smokers free of chronic diseases (e.g., diabetes, heart disease, cancer etc.), conversant in English language and able to provide informed consent as well as having a BMI within the range of 25 to 35 will be enrolled for this trial."

Answered by AI
~16 spots leftby May 2025